⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3791857 | 0.78 | GAA (0.48) | — | |
| SCHEMBL3729632 | 0.76 | — | — | |
| SCHEMBL27317175 | 0.74 | — | — | |
| SCHEMBL3729631 | 0.74 | — | — | |
| SCHEMBL19884346 | 0.74 | — | — | |
| SCHEMBL20177132 | 0.72 | — | — | |
| SCHEMBL10914515 | 0.72 | GAA (0.44) | — | |
| SCHEMBL13240158 | 0.72 | GAA (0.59) | — | |
| SCHEMBL14414190 | 0.70 | GAA (0.43) | — | |
| SCHEMBL5962495 | 0.70 | GAA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1557671-B1 | IN VITRO METHOD OF CLINICAL DIAGNOSIS. | NIHON MEDIPHYSICS CO LTD (JP) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009143156-A2 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS | SEPRACOR INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2008139941-A1 | SUBSTITUTED IMIDAZOLE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-20 | — | — | WO | disclosed |
| EP-1197227-B9 | METHOD OF THE ADMINISTRATION OF DRUGS HAVING BINDING AFFINITY WITH PLASMA PROTEIN AND PREPARATION TO BE USED IN THE METHOD | NIHON MEDIPHYSICS CO LTD (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1197227-B1 | METHOD OF THE ADMINISTRATION OF DRUGS HAVING BINDING AFFINITY WITH PLASMA PROTEIN AND PREPARATION TO BE USED IN THE METHOD | NIHON MEDIPHYSICS CO LTD (JP) | 2007-09-12 | — | — | EP | disclosed |
| US-7175991-B2 | Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20060166269-A1 | Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060140857-A1 | Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method | NIHON MEDI-PHYSICS CO., LTD. | 2006-06-29 | — | — | US | disclosed |
| US-7029653-B1 | Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| EP-1557671-A1 | METHOD OF MEASURING BINDING SITE ON PLASMA PROTEIN OF PLASMA PROTEIN-BINDING DRUG AND METHOD OF MEASURING PLASMA PROTEIN MUTATION | Nihon Medi-Physics Co., Ltd. (JP) | 2005-07-27 | — | — | EP | disclosed |
| EP-1197227-A1 | METHOD OF THE ADMINISTRATION OF DRUGS HAVING BINDING AFFINITY WITH PLASMA PROTEIN AND PREPARATION TO BE USED IN THE METHOD | Nihon Medi-Physics Co., Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |